SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-010966
Filing Date
2018-08-14
Accepted
2018-08-14 14:53:47
Documents
43
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_wizepharmainc.htm 10-Q 514270
2 CERTIFICATION f10q0618ex31-1_wizepharmaltd.htm EX-31.1 15786
3 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 f10q0618ex32-1_wizepharmaltd.htm EX-32.1 8582
  Complete submission text file 0001213900-18-010966.txt   3015591

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE wizp-20180630.xsd EX-101.SCH 33832
5 XBRL INSTANCE FILE wizp-20180630.xml EX-101.INS 552074
6 XBRL CALCULATION FILE wizp-20180630_cal.xml EX-101.CAL 27731
7 XBRL DEFINITION FILE wizp-20180630_def.xml EX-101.DEF 129249
8 XBRL LABEL FILE wizp-20180630_lab.xml EX-101.LAB 304746
9 XBRL PRESENTATION FILE wizp-20180630_pre.xml EX-101.PRE 210432
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 181016561
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1